01 October 2007
Olfactory and psychomotor symptoms in HIV and aging: Potential precursors to cognitive loss
David E VanceMed Sci Monit 2007; 13(10): SC1-3 :: ID: 502451
Abstract
In the United States, more than 100,000 adults 50 years old and over are diagnosed with the Human Immunodeficiency Virus (HIV). The number of older adults living with HIV is increasing dramatically due primarily to Highly Active Antiretroviral Therapy (HAART) which is transforming this disease into a chronic condition for many who are responding well to treatment. This population is also growing due to later-life infections and reflects the overall aging of the larger population in general. Yet, despite the novelty of such developing demographic trends, the negative consequences of aging with HIV are largely unknown. Therefore, it is necessary to synthesize the gerontological and HIV/AIDS literatures to hypothesize possible areas that may be of concern to people as they age with this disease. One area of particular concern focuses on tell-tale signs of cognitive problems and the development of dementia. Separately, older adults and adults with HIV are more susceptible of experiencing cognitive declines and dementia. Thus, as people age with HIV, they may be particularly susceptible of such cognitive problems and therefore detecting such problems in the early stages may be vital in preventing further problems. Based on the literature, adults infected with HIV experience impairments in olfaction and psychomotor ability. Similar symptoms are exhibited in older adults with Parkinson’s disease and other dementias. Thus, for older adults with HIV, declines in both olfaction and psychomotor skills may be early signs of a developing neurodegenerative disorder. Implications for those aging with HIV are posited.
Keywords: Cognition Disorders - physiopathology, Aging - pathology, AIDS Dementia Complex - physiopathology, Olfactory Nerve Diseases - physiopathology, Psychomotor Disorders - physiopathology, AIDS Dementia Complex - physiopathology, Aging - pathology, Cognition Disorders - physiopathology, Olfactory Nerve Diseases - physiopathology, Psychomotor Disorders - physiopathology
607 4
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
31 May 2023 : Review article
Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical Research
A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review article
A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952